Exploring the link between metabolic dysfunction-associated fatty liver disease and subclinical hypothyroidism in adolescents: a comprehensive review
In adolescents, MAFLD and SCH appear linked through metabolic and endocrine pathways, but causality remains unproven. Risk-based screening may be warranted-thyroid testing in MAFLD and targeted liver assessment in persistent SCH-while longitudinal cohorts and pediatric trials are needed to define thresholds for intervention and potential benefits of endocrine management.
Authors
- Guoshuai Xu
- Wenqiang Li (ORCID: https://orcid.org/0000-0002-0833-246X)
- Wenzai Shi
- Nan Yao
- Guoyong Yu
- Jun Qu
- Xinlong Hu
Institutions
- Peking University (CN)
- Aerospace Center Hospital (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
- Peking University International Hospital (CN)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2026-02-16
- DOI
- https://doi.org/10.3389/fped.2026.1696331
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00